Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Again a dogma that collapses: that of the strictly cytoplasmic synthesis of proteins].

Bulletin du cancer·2001
Same author

[STI571: the resistance organizes!].

Bulletin du cancer·2001
Same author

[It is not only smoke in tobacco that is bad, nicotine is not good either].

Bulletin du cancer·2001
Same author

[Oncolytic viruses: sea serpent, virtual reality or real therapeutic virtue].

Bulletin du cancer·2001
Same author

[Hormones, platinum, and cancer of the breast].

Bulletin du cancer·2000
Same author

[Perhaps an explanation for the therapeutic escape of prostate cancer treated with antiandrogens].

Bulletin du cancer·2000

Related Experiment Video

Updated: Jun 6, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

[miRNAs and cancer].

P Jeanteur1

  • 1Institut de génétique moléculaire de Montpellier, 34293 Montpellier cedex 05, France. philippe.jeanteur@igmm.cnrs.fr

Bulletin Du Cancer
|November 10, 2010
PubMed
Summary
This summary is machine-generated.

MicroRNAs (miRNAs), small RNAs regulating gene expression, have a history predating their 1993 rediscovery. These molecules play a crucial role in gene regulation and are implicated in various diseases, including cancer.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Context:

  • The historical understanding of gene regulation has primarily focused on DNA's role.
  • Small regulatory RNAs, like microRNAs (miRNAs), have emerged as critical players in gene expression control.
  • The discovery and characterization of miRNAs have significantly advanced our understanding of biological processes.

Purpose:

  • To provide a historical perspective on the concept of microRNA (miRNA).
  • To highlight the 'rediscovery' and subsequent intense research into miRNAs since 1993.
  • To emphasize the significant role of miRNAs in gene expression regulation and their involvement in physiological and pathological conditions, particularly cancer.

Summary:

  • The concept of microRNAs (miRNAs) dates back 35 years to the identification of translational control RNAs (tcRNAs).
  • Although initially overlooked, miRNAs were rediscovered in 1993, sparking extensive research into their function, biosynthesis, and involvement in various biological processes.
  • miRNAs are crucial regulators of gene expression, impacting both physiological and pathological states, with notable implications in cancer development and progression.

Impact:

  • This review underscores the profound impact of RNA, specifically miRNAs, on gene expression regulation and dysregulation.
  • It challenges the traditional view of cancer's origins solely in DNA, highlighting the quantitative and qualitative control exerted by miRNAs.
  • The findings emphasize the need to consider miRNAs as key factors in understanding complex diseases and developing novel therapeutic strategies.